Sigyn Therapeutics (SIGY) Research & Development (2020 - 2025)
Sigyn Therapeutics' (SIGY) quarterly Research & Development came in at $29681.0 in Q3 2025, down 85.6% year-over-year from $206161.0 in Q3 2024, and up 296.7% quarter-over-quarter from $7482.0 in Q2 2025.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Research & Development (2020 - 2025) Analysis & Trends
Sigyn Therapeutics has disclosed Research & Development across 6 years of filings, most recently posting $29681.0 for Q3 2025.
- In Q3 2025, Research & Development fell 85.6% year-over-year to $29681.0; the TTM figure through Sep 2025 stood at $140101.0 (down 84.35% YoY), while the FY2024 annual figure was $773279.0, down 3.12% from the prior year.
- Research & Development came in at $29681.0 for Q3 2025 at Sigyn Therapeutics, up from $7482.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $250259.0 in Q4 2021 to a low of $7482.0 in Q2 2025.
- Average Research & Development over 5 years is $158374.7, with a median of $154683.0 recorded in 2022.
- Year-over-year, Research & Development surged 5790.6% in 2021 and slumped 96.89% in 2025.
- Over 5 years, Research & Development stood at $250259.0 in 2021, then slumped by 43.71% to $140861.0 in 2022, then surged by 53.3% to $215933.0 in 2023, then sank by 56.42% to $94096.0 in 2024, then tumbled by 68.46% to $29681.0 in 2025.
- Per Business Quant data, the three most recent Research & Development figures were $29681.0 in Q3 2025, $7482.0 in Q2 2025, and $8842.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 29,681.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 29,681.00 |
| Jun 30, 2025 | 7,482.00 |
| Mar 31, 2025 | 8,842.00 |
| Dec 31, 2024 | 94,096.00 |
| Sep 30, 2024 | 206,161.00 |
| Jun 30, 2024 | 240,429.00 |
| Mar 31, 2024 | 232,593.00 |
| Dec 31, 2023 | 215,933.00 |
| Sep 30, 2023 | 215,230.00 |
| Jun 30, 2023 | 219,159.00 |
| Mar 31, 2023 | 147,843.00 |
| Dec 31, 2022 | 140,861.00 |
| Sep 30, 2022 | 133,770.00 |
| Jun 30, 2022 | 154,683.00 |
| Mar 31, 2022 | 228,342.00 |
| Dec 31, 2021 | 250,259.00 |
| Sep 30, 2021 | 227,503.00 |
| Jun 30, 2021 | 139,736.00 |
| Mar 31, 2021 | 116,516.00 |
| Dec 31, 2020 | 417,384.00 |